Safety and pharmacokinetics of anti-TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial - Chowdary, P; Lethagen, S; Friedrich, U (J Thromb Haemost, 2015)
, et al.